Our results are also in good agreement with the recent finding that both de novo DNMTs showed a different pattern of expression relative to DNMT1 during carcinogenesis, with an overexpression in early cancer stages and a final reduced expression in tumors [60]. The gene discussed is DNMT1; the disease is cancer.